1[1]Cardiac Arrhythmia Suppression Trial(CAST) Investigator. Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989, 321:406
2[2]Cardiac Arrhythmia Suppression Trial (CAST) Ⅱ investigator. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992,327:227
3[3]Print CM, et al. Can antiarrhythmic drugs survive survival trials? Am J Cardiol. 1998,81 (6A) :24D
4[4]Julian DG, et al. Randomized Trial of effect of anmiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction:EMIAT. lancet, 1997,439: 667
5[5]Caims JA, et al. Randomised Trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations:CAMIAT. Lancet, 1997,349: 675
6[6]Singh SN, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Eng I J Med, 1995,333: 77
7[7]Wald A, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet, 1996,348:7
8[8]Pederson OD, et al. Efficacy of dofetilide in the treatment of atrial fibrillationflutter in patients with arrythmia and mortality on dofetilide (diamond) substudy. Circulation, 2001,104(3) :7
9[9]First international study of infarct survival collaborative goup. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS- J . Lancet, 1986,2(8498)57
10[10]Heidenreich PA, et al. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol.1997,30:27
